Developments in blood-brain barrier penetrance and drug repurposing for improved treatment of glioblastoma BG Harder, MR Blomquist, J Wang, AJ Kim, GF Woodworth, JA Winkles, ... Frontiers in oncology 8, 462, 2018 | 148 | 2018 |
Temporospatial genomic profiling in glioblastoma identifies commonly altered core pathways underlying tumor progression MR Blomquist, SF Ensign, F D’Angelo, JJ Phillips, M Ceccarelli, S Peng, ... Neuro-oncology advances 2 (1), vdaa078, 2020 | 17 | 2020 |
Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures LS Hu, F D’Angelo, TM Weiskittel, FP Caruso, SP Fortin Ensign, ... Nature communications 14 (1), 6066, 2023 | 7 | 2023 |
A novel transcriptional complex of OLIG2-STAT5 mediates glioma stem cell self renewal and invasion A Miller, C Lo Cascio, M Blomquist, JB McNamara, K Orndorff, M Dufault, ... Cancer Research 84 (6_Supplement), 256-256, 2024 | | 2024 |
EGFR missense mutation (s) induce OLIG2 expression to regulate glioma stem cells maintenance and therapeutic resistance S Weaver, A Miller, M Blomquist, J McNamara, K Orndorff, C Sereduk, ... Cancer Research 84 (6_Supplement), 5444-5444, 2024 | | 2024 |
EGFRvIII Confers Sensitivity to Saracatinib in a STAT5-Dependent Manner in Glioblastoma MR Blomquist, R Eghlimi, A Beniwal, D Grief, DG Nascari, L Inge, ... International Journal of Molecular Sciences 25 (11), 6279, 2024 | | 2024 |
STAT5-OLIG2 TRANSCRIPTIONAL COMPLEX MEDIATES GLIOMA STEM CELL SELF RENEWAL AND INVASION A Miller, C Lo Cascio, M Blomquist, J McNamara, K Orndorff, M Dufault, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
REGULATION OF GLIOMA STEM CELL MAINTENANCE AND THERAPEUTIC RESISTANCE BY EGFR MISSENSE MUTATIONS S Weaver, A Miller, M Blomquist, J McNamara, K Orndorff, J Kloss, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
INNV-20. PREDICTING RESPONSE TO CHEMOTHERAPY IN HIGH GRADE GLIOMAS USING EX VIVO 3D CELL CULTURE FUNCTIONAL PRECISION … M Mrugala, M Hrachova, W Sherman, SF Ensign, M Blomquist, A Porter, ... Neuro-Oncology 25 (Supplement_5), v160-v161, 2023 | | 2023 |
The following chapter presents a portion of the study “Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures … M Blomquist, LS Hu, F D’Angelo, T Weiskittel, F Pia TARGETING RECURRENCE IN GLIOBLASTOMA, 74, 2023 | | 2023 |
CHAPTER II. TEMPOROSPATIAL GENOMIC PROFILING IN GLIOBLASTOMA IDENTIFIES COMMONLY ALTERED CORE PATHWAYS UNDERLYING TUMOR PROGRESSION MR Blomquist, SF Ensign, F D’Angelo, JJ Phillips TARGETING RECURRENCE IN GLIOBLASTOMA, 43, 2023 | | 2023 |
Multi-parametric MRI maps regional heterogeneity of high grade glioma phenotypes M Flick, T Weiskittel, K Meng-Lin, F D'Angelo, F Caruso, S Ensign, ... Cancer Research 83 (7_Supplement), 5621-5621, 2023 | | 2023 |
Multiregional sampling of high grade glioma identifies regional biologic signatures MR Blomquist, LS Hu, F D'Angelo, TM Weiskittel, FP Caruso, SPF Ensign, ... Cancer Research 83 (7_Supplement), 1507-1507, 2023 | | 2023 |
Role of TWEAK-Fn14 axis in driving immunosuppression in glioblastoma multiforme A Beniwal, R Eghlimi, KD Alexander, MR Blomquist, N Tran Cancer Research 83 (7_Supplement), 6442-6442, 2023 | | 2023 |
Targeting Recurrence in Glioblastoma MR Blomquist College of Medicine-Mayo Clinic, 2023 | | 2023 |
JAK-independent STAT5 signaling as a node of therapeutic vulnerability in glioblastoma M Blomquist, S Tuncali, C Sereduk, J Kloss, J Loftus, N Tran Cancer Research 82 (12_Supplement), 101-101, 2022 | | 2022 |
ABT-414 RESISTANT GBM TUMORS HARBOR THE TEK S466I MUTATION AND EXHIBIT INCREASED STEMNESS M Blomquist, T Noviello, F D'Angelo, C Sereduk, B Rabichow, A Miller, ... NEURO-ONCOLOGY 23, 34-35, 2021 | | 2021 |
Neuro-Oncology Advances MR Blomquist, SF Ensign, F D’Angelo, JJ Phillips, M Ceccarelli, S Peng, ... | | 2020 |
WEE1 inhibition suppresses esophageal adenocarcinoma tumor growth both in vitro and in vivo M Blomquist, VM Carson, RM Bremner, TG Whitsett, LJ Inge Cancer Research 78 (13_Supplement), 1526-1526, 2018 | | 2018 |